-- Sanofi Is Studying Israeli Flu-Vaccine Developer BiondVax, Les Echos Says
-- David Whitehouse
-- 2010-06-18T04:25:30Z
-- http://www.bloomberg.com/news/2010-06-18/sanofi-is-studying-israeli-flu-vaccine-developer-biondvax-les-echos-says.html

          
          
             Sanofi-Aventis SA is studying
BiondVax Pharmaceuticals Ltd., an Israeli company that is
seeking to develop a universal flu vaccine, French daily Les
Echos reported, without saying where it got the information.  
 The two companies, which have regular talks, are not in
exclusive negotiations, the newspaper said. BiondVax has a
market value of about 83 million shekels ($22 million).  
          
          


  


        